This Study is Being Performed to Evaluate the Effect of Genasense on the Efficacy and the Safety of Rituximab/Fludarabine Combination Treatment in Previously Untreated Subjects With Chronic Lymphocyctic Leukemia(CLL)
Clinical trial NCT00517218 · WITHDRAWN
Trial details
- NCT number
- NCT00517218
- Sponsor
- Genta Incorporated
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-06-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.